Oppenheimer Maintains Bullish View on Sarepta (SRPT) Despite Sell-Off on FDA Briefing Documents

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Oppenheimer Maintains Bullish View on Sarepta (SRPT) Despite Sell-Off on FDA Briefing Documents
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 15.31 +0.31 (2.07%)
Previous Close $15.00    52 Week High $63.73 
Open $15.01    52 Week Low $8.00 
Day High $15.55    P/E N/A 
Day Low $15.01    EPS $-5.69 
Volume 2,270,393